Rezolute
This role involves developing and executing pharmacovigilance strategies for late-stage clinical development, regulatory approval, and post-marketing surveillance. The position requires establishing a scalable PV operating model and serving as a senior safety leader across multiple functions. The role also includes leading PV readiness activities for commercial launch and overseeing safety surveillance and benefit-risk management. Additionally, the position entails managing PV operations, ensuring quality and compliance, and handling partnerships and regulatory compliance.
Rezolute is a rare disease company focused on developing ersodetug, a potential treatment for hypoglycemia caused by congenital and tumor hyperinsulinism.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rezolute.
Rezolute didn’t post a salary, so this is our estimate from similar listings.
Right around the average for this role
Head of Pharmacovigilance
CytomX Therapeutics
Vice President, Pharmacovigilance & Risk Management
Celldex Therapeutics
Senior Director, Patient Safety & Pharmacovigilance
Latigobio
Vice President, Pharmacovigilance and Drug Safety (Head of Pharmacovigilance and Drug Safety)
ORIC Pharmaceuticals Inc
Vice President, Drug Safety and Pharmacovigilance
City Therapeutics
Associate Director, Pharmacovigilance Scientist
Tango Therapeutics